Acceptance or rejection of prophylactic medicine in patients with migraine: a cross-sectional study

被引:12
作者
Kol, Carianne M. C. [1 ]
Dekker, Frans [1 ]
Neven, Arie Knuistingh [1 ]
Assendelft, Willem J. J. [1 ]
Blom, Jeanet W. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands
关键词
headache; migraine; preventive therapy; prophylaxis; quality of life;
D O I
10.3399/bjgp08X264063
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Most patients with two or more migraine attacks per month do not use prophylactic medication. The aim of this study is to investigate how many patients use prophylaxis or would like to use them, and which aspects of migraine contribute to the choice to use prophylactic treatment. In a cross-sectional survey in three general practices, patients were selected who were diagnosed with migraine or had prescriptions for migraine medication. A questionnaire was sent to 283 patients and completed by 166 patients, of whom 15 were excluded. A total of 129 females and 22 males were included (median age 41 years). Most patients had two or more attacks per month (66.2%). Fifty-five per cent of patients with two or more attacks per month wanted to use prophylaxis; only 8% actually used this treatment. To get more insight into the ideas for or against prophylactic use, qualitative research is indicated.
引用
收藏
页码:98 / 101
页数:4
相关论文
共 13 条
  • [1] Belam J, 2005, BRIT J GEN PRACT, V55, P87
  • [2] The preventive treatment of migraine
    Bigal, Marcelo E.
    Lipton, Richard B.
    [J]. NEUROLOGIST, 2006, 12 (04) : 204 - 213
  • [3] Topiramate improves health-related quality of life when used to prevent migraine
    Diamond, M
    Dahlöf, C
    Papadopoulos, G
    Neto, W
    Wu, SC
    [J]. HEADACHE, 2005, 45 (08): : 1023 - 1030
  • [4] PROPRANOLOL IN THE MANAGEMENT OF RECURRENT MIGRAINE - A META-ANALYTIC REVIEW
    HOLROYD, KA
    PENZIEN, DB
    CORDINGLEY, GE
    [J]. HEADACHE, 1991, 31 (05): : 333 - 340
  • [5] KNUITSTINGH NA, 2004, HUISARTS WET, V47, P411
  • [6] A six-item short-form survey for measuring headache impact:: The HIT-6™
    Kosinski, M
    Bayliss, MS
    Bjorner, JB
    Ware, JE
    Garber, WH
    Batenhorst, A
    Cady, R
    Dahlöf, CGH
    Dowson, A
    Tepper, S
    [J]. QUALITY OF LIFE RESEARCH, 2003, 12 (08) : 963 - 974
  • [7] Lamberts H., 1987, ICPC. International Classification of Primary Care
  • [8] Migraine prevalence, disease burden, and the need for preventive therapy
    Lipton, R. B.
    Bigal, M. E.
    Diamond, M.
    Freitag, F.
    Reed, M. L.
    Stewart, W. F.
    [J]. NEUROLOGY, 2007, 68 (05) : 343 - 349
  • [9] Migraine in the United States - Epidemiology and patterns of health care use
    Lipton, RB
    Scher, AI
    Kolodner, K
    Liberman, J
    Steiner, TJ
    Stewart, WF
    [J]. NEUROLOGY, 2002, 58 (06) : 885 - 894
  • [10] *QUAL INC GLAXOSMI, HEAD IMP TEST HIT NE